The AHA, joined by several other national groups representing 340B hospitals, Feb. 19 urged the Health Resources and Services Administration to extend the timeline for stakeholders to submit comments to the agency’s recent request for information on a new 340B rebate model program.

Specifically, the groups urged HRSA to extend the comment deadline to April 20 to give stakeholders sufficient time to gather information and provide complete answers to dozens of detailed questions contained in the RFI. The current deadline for comments is March 19.

“In general, this timeline would better allow stakeholders, including the 340B hospital field, to provide the agency with meaningful feedback,” the groups wrote. “As HRSA has previously recognized, a rebate mechanism would upend more than 30 years of practice using an upfront discount mechanism. This modest extension is necessary to fulfill the agency’s own stated goal of ensuring ‘a fair and transparent comment process for all stakeholders.’ Indeed, without an extension, we have serious concerns whether the agency will be able to consider all aspects of the problem.”

In addition to the AHA, today’s letter was signed by America’s Essential Hospitals, American Society of Health-Systems Pharmacists, Association of American Medical Colleges, Catholic Health Association of the United States, Children’s Hospital Association, and 340B Health. 

Related News Articles

Headline
The Minnesota Court of Appeals Feb. 17 affirmed a lower court decision in ruling that the state’s 340B contract pharmacy law is not preempted by federal law.…
Headline
The Department of Health and Human Services Feb. 13 issued a request for information on a new 340B rebate model program. The RFI said HHS’ Health Resources and…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law. The state law prohibits…
Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…